| Kevin M Robertson, MD | |
|
3205 Glacier Ridge Rd, Middleton, WI 53562-1765 | |
| (608) 833-3274 | |
| (608) 833-8007 |
| Full Name | Kevin M Robertson |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 3205 Glacier Ridge Rd, Middleton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447313747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 37842-020 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin M Robertson, MD 3205 Glacier Ridge Rd, Middleton, WI 53562-1765 Ph: (608) 833-3274 | Kevin M Robertson, MD 3205 Glacier Ridge Rd, Middleton, WI 53562-1765 Ph: (608) 833-3274 |
News Archive
An analysis of the medical records of patients treated at Massachusetts General Hospital (MGH) for an often-mysterious condition involving damage to small nerve fibers supports the hypothesis that some cases are caused by autoimmune disease and also identifies the first effective treatment option.
It takes life-saving research and access to clinical trials to help children with cancer. The St. Baldrick's Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, awarded an infrastructure grant of $47,000 to the Biopathology Center (BPC), housed in The Research Institute at Nationwide Children's Hospital.
Writing in the January 3 issue of Cancer Cell, researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expects to launch midazolam, which will be offered in latex-free vials, in 2011. According to 2010 IMS data, the annual U.S. market for injectable midazolam approximated $52 million.
AgaMatrix, Inc., the makers of WaveSense blood glucose meters, announced today their continued commitment to educate health care professionals and patients on the importance of blood glucose meter (BGM) accuracy for all patients.
› Verified 7 days ago